FDA Approved: COTELLIC — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for COTELLIC (cobimetinib) from Genentech, expanding its labeling. The action relates to the treatment of malignant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Cotellic (cobimetinib)

Snippet

SUPPL AP for COTELLIC (COBIMETINIB)